A PHASE I FIRST-IN-HUMAN STUDY IN HEALTHY VOLUNTEERS WITH INTRAVENOUSLY ADMINISTERED OMN6, A NOVEL ANTIMICROBIAL PEPTIDE TARGETING ACINETOBACTER BAUMANNII
QPS worked closely with Omnix Medical Ltd. to present the results of a Phase I first-in-human study in healthy volunteers with intravenously administered OMN6.
PHASE 1 EVALUATION OF THE SAFETY, TOLERABILITY AND PLASMA AND CSF PHARMACOKINETICS OF AST-004 AFTER IV INFUSION IN HEALTHY VOLUNTEERS
Peter Dogterom, PhD presents the Phase 1 evaluation of the safety, tolerability and plasma and CSF pharmacokinetics of AST-004 after IV infusion in healthy volunteers.
RELATIVE BIOAVAILABILITY AND FOOD EFFECT STUDY WITH A NEW TABLET FORMULATION OF SELVIGALTIN (GB1211) IN HEALTHY VOLUNTEERS
Peter Dogterom, PhD presents the relative bioavailability and food effect study with a new tablet formulation of selvigaltin (GB1211) in healthy volunteers.
EXPERIENCES OF CSF COLLECTION BY SERIAL SAMPLING OR LUMBAR PUNCTURE IN CLINICAL PHARMACOLOGY RESEARCH
Peter Dogterom, PhD presented Experiences of CSF collection by serial sampling or lumbar puncture in clinical pharmacology research at ASCPT 2023 in March 2023.
PARTIAL METHOD VALIDATION OF BIOMARKER ASSAYS TO DETERMINE ADRENOCORTICOTROPIC HORMONE (ACTH) CONCENTRATIONS IN RAT AND CANINE SERUM IN SUPPORT OF PRE-CLINICAL ENDOCRINOLOGY DRUG DEVELOPMENT
Michael Sonnenfelt presented Partial Method Validation of Biomarker Assays to Determine Adrenocorticotropic Hormone (ACTH) Concentrations in Rat and Canine Serum in Support of Pre-Clinical Endocrinology Drug Development in collaboration with Crinetics, at WRIB in June 2023.
GRIMACE SCALE AS A ROBUST METRIC FOR NOCICEPTION IN A NITROGLYCERIN (NTG)-INDUCED MOUSE MIGRAINE MODEL.
Aaron Fantina- Woblistin, Roland Rabl, Livia Breznik, Laurenz Jauk, Magdalena Daurer, Tina Löffler, Manuela Prokesch
IN VITRO SCREENING TOOLS TO ASSESS EFFECTS OF PSYCHEDELIC SUBSTANCES ON STRUCTURAL AND FUNCTIONAL NEUROPLASTICITY IN RAT PRIMARY NEURONS.
Stefanie Krassnig, Roland Rabl, Tina Löffler, Irene Schilcher, Magdalena Daurer, Sara Peinkiher, Stefanie Flunkert, Manuela Prokesch
PHENOTYPIC CHARACTERIZATION OF hA53Ttg MICE AS PARKINSON’S DISEASE MODEL
Tina Loeffler, Marlene Mikusch, Richard Scheytt, Joerg Neddens, Roland Rabl, Magdalena Daurer, Livia Breznik, Sara Peinkiher, Stefanie Flunkert, Spyridon Sideromenos, Manuela Prokesch
NEUROINFLAMMATION IN THE EAE MODEL OF MULTIPLE SCLEROSIS
Joerg Neddens, Magdalena Daurer, Livia Breznik, Roland Rabl, Tina Loeffler, Sara Peinkiher, Stefanie Flunkert, Manuela Prokesch